{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T13:09:16Z","timestamp":1761311356458,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.vaccine.2018.04.021","type":"journal-article","created":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T22:01:49Z","timestamp":1524088909000},"page":"3010-3017","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Inactivated influenza vaccine stress can affect in vitro potency assay relationship to immunogenicity"],"prefix":"10.1016","volume":"36","author":[{"given":"Yingxia","family":"Wen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Palladino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ethan C.","family":"Settembre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.04.021_b0005","doi-asserted-by":"crossref","unstructured":"Zambon MC. Epidemiology and pathogenesis of influenza. J Antimicrob Chemother, 1999;44 Suppl B:3\u20139.","DOI":"10.1093\/jac\/44.suppl_2.3"},{"issue":"17\u201319","key":"10.1016\/j.vaccine.2018.04.021_b0010","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1016\/S0264-410X(00)00448-5","article-title":"Influenza vaccines: a review and rationale for use in developed and underdeveloped countries","volume":"19","author":"Poland","year":"2001","journal-title":"Vaccine"},{"issue":"5796","key":"10.1016\/j.vaccine.2018.04.021_b0015","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/289373a0","article-title":"Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation","volume":"289","author":"Wiley","year":"1981","journal-title":"Nature"},{"issue":"5796","key":"10.1016\/j.vaccine.2018.04.021_b0020","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/289366a0","article-title":"Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution","volume":"289","author":"Wilson","year":"1981","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.vaccine.2018.04.021_b0025","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1006\/viro.2002.1625","article-title":"Mechanism of neutralization of influenza virus infectivity by antibodies","volume":"302","author":"Knossow","year":"2002","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2018.04.021_b0030","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0022-2836(77)80149-6","article-title":"Crystallization and x-ray diffraction studies on the haemagglutinin glycoprotein from the membrane of influenza virus","volume":"112","author":"Wiley","year":"1977","journal-title":"J Mol Biol"},{"issue":"6492","key":"10.1016\/j.vaccine.2018.04.021_b0035","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/371037a0","article-title":"Structure of influenza haemagglutinin at the pH of membrane fusion","volume":"371","author":"Bullough","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2018.04.021_b0040","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.biochem.69.1.531","article-title":"Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin","volume":"69","author":"Skehel","year":"2000","journal-title":"Annu Rev Biochem"},{"issue":"Pt 11","key":"10.1016\/j.vaccine.2018.04.021_b0045","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1099\/0022-1317-69-11-2785","article-title":"Studies on the structure of the influenza virus haemagglutinin at the pH of membrane fusion","volume":"69","author":"Ruigrok","year":"1988","journal-title":"J Gen Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2018.04.021_b0050","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/0042-6822(86)90210-2","article-title":"Conformational changes in the hemagglutinin of influenza virus which accompany heat-induced fusion of virus with liposomes","volume":"155","author":"Ruigrok","year":"1986","journal-title":"Virology"},{"issue":"26","key":"10.1016\/j.vaccine.2018.04.021_b0055","doi-asserted-by":"crossref","first-page":"14306","DOI":"10.1073\/pnas.94.26.14306","article-title":"Influenza hemagglutinin is spring-loaded by a metastable native conformation","volume":"94","author":"Carr","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6535","key":"10.1016\/j.vaccine.2018.04.021_b0060","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/376092a0","article-title":"Structure of influenza virus haemagglutinin complexed with a neutralizing antibody","volume":"376","author":"Bizebard","year":"1995","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.vaccine.2018.04.021_b0065","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.virol.2011.05.014","article-title":"Immunogenicity of low-pH treated whole viral influenza vaccine","volume":"417","author":"Quan","year":"2011","journal-title":"Virology"},{"issue":"29","key":"10.1016\/j.vaccine.2018.04.021_b0070","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1016\/j.vaccine.2016.04.091","article-title":"Trypsin pre-treatment corrects SRID over-estimation of immunologically active, pre-fusion HA caused by mixed immunoprecipitin rings","volume":"34","author":"Wen","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.04.021_b0075","doi-asserted-by":"crossref","unstructured":"Weldon WC, et al. Enhanced immunogenicity of stabilized trimeric soluble influenza hemagglutinin. PLoS One 2010;5(9).","DOI":"10.1371\/journal.pone.0012466"},{"issue":"19","key":"10.1016\/j.vaccine.2018.04.021_b0080","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1016\/j.vaccine.2011.02.100","article-title":"Mutations affecting the stability of the haemagglutinin molecule impair the immunogenicity of live attenuated H3N2 intranasal influenza vaccine candidates lacking NS1","volume":"29","author":"Nakowitsch","year":"2011","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2018.04.021_b0085","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0092-1157(77)80008-5","article-title":"An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: application for potency determinations of inactivated whole virus and subunit vaccines","volume":"5","author":"Wood","year":"1977","journal-title":"J Biol Stand"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2018.04.021_b0090","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0378-1135(93)90027-5","article-title":"Single-radial-immunodiffusion as an in vitro potency assay for human inactivated viral vaccines","volume":"37","author":"Williams","year":"1993","journal-title":"Vet Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2018.04.021_b0095","first-page":"223","article-title":"A single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen. Proposals for an assay method for the haemagglutinin content of influenza vaccines","volume":"52","author":"Schild","year":"1975","journal-title":"Bull World Health Organ"},{"issue":"83","key":"10.1016\/j.vaccine.2018.04.021_b0100","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/newbio238145a0","article-title":"Crystalline antigen from the influenza virus envelope","volume":"238","author":"Brand","year":"1972","journal-title":"Nat New Biol"},{"issue":"41","key":"10.1016\/j.vaccine.2018.04.021_b0105","doi-asserted-by":"crossref","first-page":"5342","DOI":"10.1016\/j.vaccine.2015.08.077","article-title":"Conformationally selective biophysical assay for influenza vaccine potency determination","volume":"33","author":"Wen","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.04.021_b0110","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3390\/vaccines3010090","article-title":"Assaying the potency of influenza vaccines","volume":"3","author":"Minor","year":"2015","journal-title":"Vaccines"},{"issue":"4","key":"10.1016\/j.vaccine.2018.04.021_b0115","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1073\/pnas.79.4.968","article-title":"Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion","volume":"79","author":"Skehel","year":"1982","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2018.04.021_b0120","first-page":"97","article-title":"Factors affecting the stability of viral vaccines","volume":"87","author":"Peetermans","year":"1996","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2018.04.021_b0125","first-page":"135","article-title":"Analysis of vaccine stability","volume":"87","author":"Volkin","year":"1996","journal-title":"Dev Biol Stand"},{"issue":"3 Suppl","key":"10.1016\/j.vaccine.2018.04.021_b0130","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0264-410X(85)90109-4","article-title":"Stability of infectious influenza A viruses at low pH and at elevated temperature","volume":"3","author":"Scholtissek","year":"1985","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.04.021_b0135","unstructured":"WHO Expert Committee on Biological Standardization. Thirtieth report. World Health Organ Tech Rep Ser, 1979; 638:1\u2013199."},{"issue":"5","key":"10.1016\/j.vaccine.2018.04.021_b0140","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.biologicals.2014.05.007","article-title":"Vaccine instability in the cold chain: mechanisms, analysis and formulation strategies","volume":"42","author":"Kumru","year":"2014","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2018.04.021_b0145","unstructured":"Grabenstein JD. ImmunoFacts; vaccines and immunologic drugs 2013. Saint Louis, Mo.: Wolters Kluwer Health\/Facts & Comparisons; 2012."},{"issue":"2","key":"10.1016\/j.vaccine.2018.04.021_b0150","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0003-9861(59)90209-7","article-title":"Effect of freezing on the pH and composition of sodium and potassium phosphate solutions; the reciprocal system KH2PO4-Na2-HPO4-H2O","volume":"81","author":"Van Den Berg","year":"1959","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"10.1016\/j.vaccine.2018.04.021_b0155","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejps.2004.05.007","article-title":"Physicochemical studies on the stability of influenza haemagglutinin in vaccine bulk material","volume":"23","author":"Luykx","year":"2004","journal-title":"Eur J Pharm Sci"},{"issue":"5","key":"10.1016\/j.vaccine.2018.04.021_b0160","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1128\/CVI.00701-15","article-title":"Mechanistic analysis of the effect of deamidation on the immunogenicity of anthrax protective antigen","volume":"23","author":"Verma","year":"2016","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2018.04.021_b0165","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1006\/jcis.1999.6255","article-title":"Protein denaturation in foam","volume":"215","author":"Clarkson","year":"1999","journal-title":"J Colloid Interface Sci"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18304900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18304900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:25:50Z","timestamp":1759400750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18304900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":33,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0264410X18304900"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.04.021","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inactivated influenza vaccine stress can affect in vitro potency assay relationship to immunogenicity","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.04.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}